SCHEMBL1306787

SCHEMBL1306787

COc1ccc(CCNC(=O)/C(=C/c2ccc(C(=O)O)cc2)COc2cccc3ccccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 2/20 0.48
▸ LMNA P02545 4/20 0.48
▸ HTT P42858 2/20 0.48
▸ PLAAT3 P53816 3/20 0.47
▸ PLAAT5 Q96KN8 3/20 0.47
▸ PLAAT2 Q9NWW9 3/20 0.47
▸ PLAAT4 Q9UL19 3/20 0.47
▸ HPGD P15428 1/20 0.47
▸ MCL1 Q07820 1/20 0.47
▸ MAPT P10636 3/20 0.46
▸ ALDH1A1 P00352 4/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ POLB P06746 2/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CAPN1 P07384 4/20 0.43
▸ GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306788 1.00 PTPN1 (0.48) PTPN1LMNAHTTPLAAT3PLAAT5
SCHEMBL1307099 0.93 PTPN1 (0.48) PTPN1LMNAHTTPLAAT3PLAAT5
SCHEMBL1306720 0.92 MAPT (0.53) LMNAHPGDMAPTALDH1A1MEN1
SCHEMBL1306717 0.92 MAPT (0.53) LMNAHPGDMAPTALDH1A1MEN1
SCHEMBL1306614 0.91 HDAC3 (0.47) PTPN1LMNAPLAAT3PLAAT5PLAAT2
SCHEMBL1306610 0.91 HDAC3 (0.47) PTPN1LMNAPLAAT3PLAAT5PLAAT2
SCHEMBL1307912 0.90 LMNA (0.51) LMNAHTTPLAAT3PLAAT5PLAAT2
SCHEMBL1307916 0.90 LMNA (0.51) LMNAHTTPLAAT3PLAAT5PLAAT2
SCHEMBL1307100 0.89 PTPN1 (0.45) PTPN1LMNAHTTPLAAT3PLAAT5
SCHEMBL27784527 0.89 LMNA (0.48) LMNAHTTHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2913322-A2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same Korea Research Institute Of Chemical Technology (KR) 2015-09-02 — — EP disclosed
US-8053435-B2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-11-08 — — US disclosed
US-20100069630-A1 NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-03-18 — — US disclosed
EP-2089354-A1 NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Korea Research Institute Of Chemical Technology (KR) 2009-08-19 — — EP disclosed
WO-2008054154-A1 NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-05-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069630-A1 NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC1, HDAC3, HDAC11 PTPN1 2544/4885LMNA 1637/4885HTT 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback